Related Experiment Videos
An update on coronary heart disease in women
1Department of Medicine, Division of Cardiology, Emory University School of Medicine, Atlanta, Georgia 30303, USA.
Insights
Coronary heart disease (CHD) is a major cause of death for US women. Women experience higher mortality and morbidity from CHD events and procedures compared to men, highlighting the need for prevention.
Area of Science:
- Cardiology
- Women's Health
- Public Health
Background:
- Coronary heart disease (CHD) is the primary cause of mortality for adult women in the United States.
- CHD leads to significant morbidity and disability in women, especially older women.
Purpose of the Study:
- To underscore the need for preventive interventions for women across their lifespan.
- To highlight recent advancements in addressing CHD as a health problem for women.
Main Methods:
- The abstract does not detail specific methods but reviews existing data on CHD outcomes in women.
- Analysis of mortality and morbidity rates following myocardial infarction and revascularization procedures.
Main Results:
- Women have higher mortality rates than men following myocardial infarction.
- Women experience poorer outcomes after coronary artery bypass graft surgery and percutaneous transluminal coronary angioplasty compared to men.
Conclusions:
- Increased case fatality and morbidity rates in women necessitate lifelong preventive strategies.
- Current efforts focus on prevention, prompt chest pain evaluation, and appropriate revascularization, with ongoing research into women-specific interventions.
Abstract:
Coronary heart disease is the leading cause of mortality for adult women in the United States, accounting for the death of nearly 250,000 women each year. Once coronary disease becomes clinically evident, it causes prominent morbidity and disability in women, particularly among older women. Women are more likely to die from an episode of myocardial infarction than are men, and first-year mortality following myocardial infarction is comparably greater for women. Similarly, women do not fare as well as men following myocardial revascularization procedures, having a greater mortality from coronary artery bypass graft surgery, less graft patency, less symptomatic relief, and more reoperation within the initial postoperative 5 years. Despite initial favorable outcomes from percutaneous transluminal coronary angioplasty, women have less long-term symptomatic relief and decreased long-term survival, the latter, however, predominantly related to their older age. The increased case fatality rates and greater morbidity of women following both myocardial infarction and myocardial revascularization procedures underscore the need for preventive interventions for women across their life span. Dramatic strides have been made in recent years, based on the recognition of the importance of coronary heart disease as a health problem for women. There is an increased emphasis on coronary preventive strategies, improvement in the prompt evaluation of chest pain syndromes, and increase in the performance of myocardial revascularization when appropriate; research is also under way to assess risk interventions unique to women.